Cancer Research Horizons Data Innovation Awards

Funding for cancer researchers to develop high quality datasets to make them suitable for sharing for use by third parties for further research and product development.

Cancer Research Horizons is a subsidiary of Cancer Research UK that functions as its translational arm to support and accelerate the translational development of innovative research into therapeutics, diagnostics and medical devices to treat and manage cancer. Cancer Research Horizons brings together its in-house drug discovery capability, development expertise, industry partners, investment finance and Cancer Research UK’s network of cutting-edge researchers, clinicians and technology to bridge the gap between discovery research and enterprise creation to bring new treatments to patients faster.

The Cancer Research Horizons Data Innovation Awards provide funding and support to help researchers develop their datasets to make them suitable for use by third parties, including commercial organisations, for further research and development. The overall aim of the awards is to enable researchers to optimise the usability and accessibility of their cancer datasets and maximise the impact and commercial potential of research funded by Cancer Research UK and other funders.

Funding is aimed at researchers who have generated a high-quality cancer dataset, or are working on a project that will generate one in the future, where there is a need for additional funding to make the dataset suitable for sharing. Funding can support cleaning, annotation, curation, linking or storage of data to produce a high-quality cancer dataset that adheres to FAIR principles (findable, accessible, interoperable, and reusable).

Cancer Research Horizons will also work with researchers to develop a long-term data-sharing strategy.